Lonza Group Ltd. Introduces Clonetics(R) Adult Melanocytes for Dermal Research

Basel / Walkersville, 27 August 2008 -- Lonza announces the availability of primary Clonetics® Adult Normal Human Epidermal Melanocytes. These are highly characterized cells for use in diverse applications in dermal research including malignant melanoma, dermal disorders, toxicology, pigmentation and cosmetic studies.
MORE ON THIS TOPIC